Uses of Phantom Sensations Induced by Global and Local Modifications of the Prosthetic Socket as Somatosensory Feedback During Walking in Lower Limb Amputees (PhantomWalk)

Following lower-limb amputation, the loss of somatosensory information from the missing limb renders walking less automatic, more cognitively demanding, and often asymmetric, which can lead to secondary pathologies.

Hypothesis: This study is based on the hypothesis that phantom limb sensations (PLS), when coherent with the prosthetic device's movements and the phases of the gait cycle, can compensate for the loss of somatosensory feedback and thereby improve locomotion for individuals with amputation. It is further hypothesized that it is possible to artificially induce these coherent and useful sensations, notably through "referred sensations" elicited by stimulation of the residual limb (e.g., via the prosthetic socket).

Objectives: The project aims to:

  • Determine whether the natural presence of phantom limb sensations during walking impacts gait parameters.
  • Confirm in a larger patient population that modifications to the prosthetic socket can induce or enhance phantom sensations that are perceived as useful for walking.
  • Investigate whether these perceptual changes (induced or enhanced) are associated with objective, measurable improvements in gait quality.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

228

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Participants with amputations:

    • Major lower limb amputation
    • Understand and be able to express oneself in the French language (for semi-structured interviews)
    • Affiliated with a social security scheme
  • Asymptomatic volunteer participants:

    • No major surgery on the lower limbs for at least 3 years
    • No minor injury to the trunk, lower or upper limbs that could influence walking for at least 1 year
    • Understand and be able to express oneself in the French language
    • Affiliated with a social security scheme

Exclusion Criteria:

  • History of psychiatric disorders
  • Pregnant or breastfeeding woman
  • Minor
  • Adult subject to a legal protection measure
  • Person under guardianship or conservatorship
  • Person under a judicial protection order
  • Pain affecting walking (trunk, residual limb, phantom limb, contralateral limb)
  • Medical treatment incompatible with walking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TT
People with transtibial amputation
Participants with unilateral amputations and a control group will undergo a comprehensive walking analysis. In a lab setting (on a treadmill or floor), their gait will be recorded using inertial sensors, EMG, force plates, and motion capture, while an EEG cap and a NASA-TLX questionnaire will assess cognitive load. Capable participants will also perform a walking test on a real-world outdoor course with varied terrain. The data will be analyzed to compare walking patterns between groups (amputees vs. controls, and amputees with vs. without phantom limbs). Finally, participants will describe any interactions they perceived between their phantom sensations and walking during the tests.
Participants reporting referred sensations in gait analysis phase will undergo further testing. The study will investigate whether prosthesis pressure or a specific socket interaction causes these sensations. A 3x3 cm grid will be drawn on the residual limb to systematically map referred sensations using various stimuli (brush, pressure tip, electrical stimulation). Participants will rate the intensity and describe the location of any resulting phantom sensations. This mapping will be repeated after 6 months to assess the stability of these sensations over time, with the ultimate goal of potentially using them to provide sensory feedback for prosthesis users. The session will last approximately 2 hours.
A semi-structured interview will be conducted to ask participants to describe their phantom limb sensations (type, location, intensity) under three conditions: without their prosthesis, while standing with it, and while walking with it. This aims to identify factors influencing these sensations. Additionally, a brief physical examination of the residual limb will be performed to see if touch in specific areas triggers any referred sensations.
Experimental: TF
People with transfemoral amputation
Participants with unilateral amputations and a control group will undergo a comprehensive walking analysis. In a lab setting (on a treadmill or floor), their gait will be recorded using inertial sensors, EMG, force plates, and motion capture, while an EEG cap and a NASA-TLX questionnaire will assess cognitive load. Capable participants will also perform a walking test on a real-world outdoor course with varied terrain. The data will be analyzed to compare walking patterns between groups (amputees vs. controls, and amputees with vs. without phantom limbs). Finally, participants will describe any interactions they perceived between their phantom sensations and walking during the tests.
Participants reporting referred sensations in gait analysis phase will undergo further testing. The study will investigate whether prosthesis pressure or a specific socket interaction causes these sensations. A 3x3 cm grid will be drawn on the residual limb to systematically map referred sensations using various stimuli (brush, pressure tip, electrical stimulation). Participants will rate the intensity and describe the location of any resulting phantom sensations. This mapping will be repeated after 6 months to assess the stability of these sensations over time, with the ultimate goal of potentially using them to provide sensory feedback for prosthesis users. The session will last approximately 2 hours.
A semi-structured interview will be conducted to ask participants to describe their phantom limb sensations (type, location, intensity) under three conditions: without their prosthesis, while standing with it, and while walking with it. This aims to identify factors influencing these sensations. Additionally, a brief physical examination of the residual limb will be performed to see if touch in specific areas triggers any referred sensations.
Unilateral transfemoral amputees with detailed referred sensation maps will have their brain activity recorded using a 64-electrode EEG cap. Non-invasive stimuli will be applied to four specific sites: an area on the residual limb that elicits a referred sensation, the corresponding location on the intact foot, a neutral area on the residual limb, and its corresponding location on the intact thigh. This process, involving 400 total stimulations, will be repeated after 6 months to track cortical changes. Non-amputee participants will also be tested as a control group to check for symmetry in brain responses to thigh stimulation. Each session lasts about 2 hours.
This phase will evaluate how socket modifications affect phantom sensations and walking in 10 transfemoral amputees. First, the best material to comfortably induce referred sensations will be determined in a small sub-study. Then, each participant will be tested under four conditions: their usual socket and a socket with different rigidity, both with and without a specific local pressure point added inside. The location of this pressure point is based on the user's sensation map. Participants' walking will be analyzed in both lab and real-world environments for each condition, and they will provide feedback on their sensations and which setup they find most helpful. The evaluation involves 4 sessions over 2-3 months
Experimental: Control
Asymptomatic people
Participants with unilateral amputations and a control group will undergo a comprehensive walking analysis. In a lab setting (on a treadmill or floor), their gait will be recorded using inertial sensors, EMG, force plates, and motion capture, while an EEG cap and a NASA-TLX questionnaire will assess cognitive load. Capable participants will also perform a walking test on a real-world outdoor course with varied terrain. The data will be analyzed to compare walking patterns between groups (amputees vs. controls, and amputees with vs. without phantom limbs). Finally, participants will describe any interactions they perceived between their phantom sensations and walking during the tests.
Unilateral transfemoral amputees with detailed referred sensation maps will have their brain activity recorded using a 64-electrode EEG cap. Non-invasive stimuli will be applied to four specific sites: an area on the residual limb that elicits a referred sensation, the corresponding location on the intact foot, a neutral area on the residual limb, and its corresponding location on the intact thigh. This process, involving 400 total stimulations, will be repeated after 6 months to track cortical changes. Non-amputee participants will also be tested as a control group to check for symmetry in brain responses to thigh stimulation. Each session lasts about 2 hours.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Characterization of phantom limb sensations
Time Frame: The first day of the study

A composite assessment of phantom limb sensations will be conducted via a semi-structured interview. Data collected will include:

  • Type of sensation (e.g., tingling, pain, movement).
  • Location (toes, heel, calf).
  • Intensity (Mild, Strong, Very Strong).
The first day of the study
Walking speed under laboratory conditions
Time Frame: The first day of the study for the control group and the second day of the study for participants with amputation
The participant's average walking speed, measured in meters per second (m/s). The measurement will be collected using inertial measurement units (IMUs) and/or a Vicon motion capture system while the participant walks on hard ground or on a treadmill at their self-selected speed.
The first day of the study for the control group and the second day of the study for participants with amputation
Step length symmetry index.
Time Frame: The first day of the study for the control group and the second day of the study for participants with amputation
Gait symmetry will be calculated based on the stride length of the affected (or corresponding) limb and the healthy limb. The symmetry index is a unitless ratio (or percentage) that quantifies the difference between the two limbs. A value of 1 (or 100%) indicates perfect symmetry. Measured using inertial measurement units or the Vicon system.
The first day of the study for the control group and the second day of the study for participants with amputation
Changes in the surface area of sensory maps referred to the residual limb
Time Frame: 2nd or 3rd day of the study depending on whether the participant with an amputation was included in phase 2 or not and during the 6-month follow-up visit.
The total surface area capable of triggering phantom sensations will be measured. For each type of stimulation (brush, pressure, point, electrical), the number of 3x3 cm areas causing a sensation will be counted. The total surface area (in cm²) will be calculated by multiplying this number by 9. A map will be generated for each stimulation modality.
2nd or 3rd day of the study depending on whether the participant with an amputation was included in phase 2 or not and during the 6-month follow-up visit.
Change in the average intensity of reported phantom sensations.
Time Frame: 2nd or 3rd day of the study depending on whether the participant with an amputation was included in phase 2 or not and during the 6-month follow-up visit.
When each reactive area is stimulated, the participant will rate the intensity of the phantom sensation perceived on a 6-point Numerical Rating Scale (NRS), ranging from 0 (no sensation) to 5 (maximum intensity imaginable). The average intensity of the reactive areas will be calculated for each type of stimulation.
2nd or 3rd day of the study depending on whether the participant with an amputation was included in phase 2 or not and during the 6-month follow-up visit.
Localization of the cortical source of somatosensory evoked potentials (SEPs) during stimulation of referred sensation areas
Time Frame: The second day of the study for participants with amputation
The recorded EEG activity will be used to model and locate the source of the maximum cortical response. The primary outcome measure will be the coordinates (e.g., in the MNI or Talairach atlas) of the center of activation in the somatosensory cortex. The objective is to compare the source localization obtained during ecological gait after each demanding walking situation.
The second day of the study for participants with amputation
Participant's subjective preference for one of the four socket conditions tested.
Time Frame: Day 7 of the study
At the end of the four test sessions, participants will be asked to rank the four conditions (rigidity A/B, with/without focal pressure) from most to least conducive to walking. The primary outcome will be the condition ranked first by the largest number of participants.
Day 7 of the study
Change in the spatiotemporal parameters of walking in ecological situations
Time Frame: Days 4 to 7 to the study
Several key walking parameters (speed in m/s, cadence in steps/min, step symmetry index) will be measured using inertial sensors during the outdoor walk. The analysis will compare the average values of these parameters between the four socket conditions.
Days 4 to 7 to the study

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Walking pace under laboratory conditions
Time Frame: The first day of the study for the control group and the second day of the study for participants with amputation
The number of steps per minute (steps/min) when walking at a comfortable speed. Measured using inertial measurement units or the Vicon system.
The first day of the study for the control group and the second day of the study for participants with amputation
Analysis of muscle co-activation in the lower limbs and trunk during walking.
Time Frame: The first day of the study for the control group and the second day of the study for participants with amputation
The electrical activity of key muscle groups (e.g., quadriceps, hamstrings, glutes, paravertebral muscles) will be recorded using surface electromyography (EMG). The analysis will focus on the timing and amplitude of muscle activation to assess motor coordination.
The first day of the study for the control group and the second day of the study for participants with amputation
Maximum vertical reaction force during walking.
Time Frame: The first day of the study for the control group and the second day of the study for participants with amputation
The maximum force exerted on the ground with each step, measured in Newtons (N) or as a percentage of body weight (%BW). The measurement will be taken using force platforms (AMTI), pressure insoles (Loadsol), or an instrumented mat (Zeno).
The first day of the study for the control group and the second day of the study for participants with amputation
Assessment of mental workload during walking using the NASA-TLX questionnaire
Time Frame: The first day of the study for the control group and the second day of the study for participants with amputation
The cognitive load perceived by the participant will be assessed using the NASA Task Load Index (NASA-TLX) self-report questionnaire. The total score, ranging from 0 to 100, will be calculated. A higher score indicates a greater perceived cognitive load.
The first day of the study for the control group and the second day of the study for participants with amputation
Analysis of brain activity related to cognitive load during walking
Time Frame: The second day of the study for participants with amputation
Electroencephalographic (EEG) activity will be recorded via a headset. Cognitive load will be quantified by analyzing the power ratio in specific frequency bands at the frontal electrodes.
The second day of the study for participants with amputation
Gait speed in ecological situation
Time Frame: The first day of the study for the control group and the second day of the study for participants with amputation
The average walking speed (in m/s) measured using inertial measurement units and pressure soles (Loadsol) during a predefined outdoor route including various difficulties (stairs, slopes, etc.).
The first day of the study for the control group and the second day of the study for participants with amputation
Qualitative description of the interaction between phantom sensations and walking
Time Frame: The second day of the study for participants with amputation
Participants' verbal descriptions of the nature of the interaction (facilitating, hindering, neutral), the evolution and characteristics of phantom sensations during walking will be collected via a structured interview at the end of the session. The data will be analyzed thematically.
The second day of the study for participants with amputation
Change in phantom limb sensation intensity at 6 months for recent amputees
Time Frame: The first day of the study and during the 6-month follow-up visit.
For the subgroup of participants with an amputation of less than 6 months at inclusion, the intensity of phantom sensations will be re-assessed using the 3-point ordinal scale.
The first day of the study and during the 6-month follow-up visit.
Effect of focal stimulation on phantom sensations
Time Frame: Day 3 of the study
For the subgroup of participants reporting interaction between sensations and focal stimulation after various stimulations using a rubber tip (pressure), a brush, and a needle. The change in sensation intensity (rated on a scale of 0 to 5). The result will be categorized as "increase," "decrease," or "no change."
Day 3 of the study
Change in perceived cognitive load (NASA-TLX score) during walking in an ecological setting
Time Frame: Day 4 to 7 of the study
Perceived mental workload will be assessed using the NASA-TLX questionnaire immediately after each walking session. The total score will be compared between the four socket conditions.
Day 4 to 7 of the study
Evaluation of socket comfort
Time Frame: Day 4 to 7 of the study
The overall comfort perceived for each condition will be assessed at the end of each session using a Numerical Rating Scale (NRS) ranging from 0 (very uncomfortable) to 10 (very comfortable). The average score will be compared between the four conditions.
Day 4 to 7 of the study
Qualitative description of the sensations reported for each socket condition
Time Frame: Day 4 to 7 of the study
For each condition, a structured description of the sensations reported (type, location, intensity, perceived usefulness for walking) will be collected through an interview. The data will be analyzed thematically to compare the sensory experience.
Day 4 to 7 of the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 16, 2024

Primary Completion (Estimated)

September 30, 2028

Study Completion (Estimated)

September 30, 2030

Study Registration Dates

First Submitted

August 21, 2025

First Submitted That Met QC Criteria

September 23, 2025

First Posted (Estimated)

September 25, 2025

Study Record Updates

Last Update Posted (Estimated)

September 25, 2025

Last Update Submitted That Met QC Criteria

September 23, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lower Limb Amputation

Clinical Trials on Gait analysis

Subscribe